Do different dialytic techniques have different atherosclerotic and antioxidant activities?

S Biasioli1, R Schiavon, L Petrosino

  • 1Nephrology and Dialysis Unit, Legnano Hospital, Italy.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|September 29, 2001
PubMed

Insights

Paired filtration dialysis (PFD) shows the best acute results in improving atherosclerosis and antioxidant activity in chronic hemodialysis patients. PFD effectively normalized atherosclerotic and antioxidant indices after a single session, unlike other dialytic techniques.

Area of Science:

  • Nephrology
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Chronic hemodialysis (HD) patients exhibit altered atherosclerosis and antioxidant status.
  • Dialytic techniques may differentially impact these metabolic parameters.

Purpose of the Study:

  • To compare the chronic effects of bicarbonate dialysis (BHD), acetate-free biofiltration (AFB), hemodiafiltration (HDF), and paired filtration dialysis (PFD) on atherosclerosis and antioxidant activity.
  • To evaluate the efficacy of different dialytic techniques in normalizing key biochemical indices.

Main Methods:

  • Development of an atherosclerotic index (AI) and an antioxidant activity index (AOAI) using plasma and erythrocyte parameters.
  • Calculation of a defense index (DI) as AOAI - AI.
  • Measurement of indices in 20 controls and 51 chronic HD patients undergoing BHD, AFB, HDF, or PFD for at least 12 months, before, during, and after a dialysis session.

Main Results:

  • HD patients showed significantly higher AI and lower AOAI compared to controls.
  • Paired filtration dialysis (PFD) demonstrated the most favorable acute results, with indices approaching normal values post-session.
  • Other techniques like BHD, AFB, and HDF showed less pronounced improvements in AI and AOAI.

Conclusions:

  • Paired filtration dialysis (PFD) appears to be the most effective dialytic technique for acutely improving markers of atherosclerosis and antioxidant activity in chronic hemodialysis patients.
  • The developed indices (AI, AOAI, DI) provide a quantitative measure to assess the impact of different dialytic strategies on oxidative stress and atherogenesis.

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...